| related words |
| dpiv |
| libigel |
| baggage |
| denies |
| pirfenidone |
| savella |
| imitation |
| workflow |
| anthrax |
| renalguard |
| pulsatile |
| molecule |
| pain |
| lasting |
| reexamination |
| tyzeka |
| macugen |
| gtl |
| antara |
| counterpart |
|
| related documents |
| 1250873--3/31/2008--CORPORATE_PROPERTY_ASSOCIATES_16_GLOBAL_INC |
| 1138301--3/31/2008--CORPORATE_PROPERTY_ASSOCIATES_15_INC |
| 1159036--3/9/2007--HALOZYME_THERAPEUTICS_INC |
| 1138301--3/26/2007--CORPORATE_PROPERTY_ASSOCIATES_15_INC |
| 1250873--3/26/2007--CORPORATE_PROPERTY_ASSOCIATES_16_GLOBAL_INC |
| 1250873--3/23/2006--CORPORATE_PROPERTY_ASSOCIATES_16_GLOBAL_INC |
| 1138301--3/30/2006--CORPORATE_PROPERTY_ASSOCIATES_15_INC |
| 722104--3/1/2010--SAVIENT_PHARMACEUTICALS_INC |
| 1159036--3/12/2010--HALOZYME_THERAPEUTICS_INC |
| 1390213--3/31/2008--Corporate_Property_Associates_17_-_Global_INC |
| 1390213--3/26/2010--Corporate_Property_Associates_17_-_Global_INC |
| 722104--3/2/2009--SAVIENT_PHARMACEUTICALS_INC |
| 1159036--3/13/2009--HALOZYME_THERAPEUTICS_INC |
| 1159036--3/14/2008--HALOZYME_THERAPEUTICS_INC |
| 1057377--4/14/2008--SAMARITAN_PHARMACEUTICALS_INC |
| 1390213--3/26/2009--Corporate_Property_Associates_17_-_Global_INC |
| 318154--3/10/2006--AMGEN_INC |
|
| related topics |
| {property, intellectual, protect} |
| {product, candidate, development} |
| {customer, product, revenue} |
| {cost, regulation, environmental} |
| {loss, insurance, financial} |
| {personnel, key, retain} |
| {loan, real, estate} |
| {cost, contract, operation} |
| {investment, property, distribution} |
| {regulation, change, law} |
| {tax, income, asset} |
| {gas, price, oil} |
| {financial, litigation, operation} |
| {cost, operation, labor} |
| {capital, credit, financial} |
| {debt, indebtedness, cash} |
| {system, service, information} |
| {interest, director, officer} |
| {acquisition, growth, future} |
| {operation, natural, condition} |
|